Literature DB >> 16816356

Role of the Survivin gene in pathophysiology.

Fengzhi Li1, Michael G Brattain.   

Abstract

Although the roles of survivin in control of cancer cell division and apoptosis as well as targeting survivin for cancer therapeutics have been extensively explored and reviewed, the pathophysiological role of survivin in normal human cells/organs has not been deeply investigated or sufficiently reviewed. Studies in the latter area, however, appear to be important for the identification of different mechanisms of regulation and function of survivin in normal versus abnormal cells and tissues (including cancer), which might ultimately provide the basis for novel approaches for disease treatment with low toxicity. This Review is intended to summarize current observations in the literature related to the physiological and/or pathological roles for survivin in various normal human cells or organs. Our view of potential future research directions for survivin pertinent to potential therapeutic applications will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816356      PMCID: PMC1698749          DOI: 10.2353/ajpath.2006.060121

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  76 in total

1.  Elevation of Survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry.

Authors:  Seiji Fukuda; Louis M Pelus
Journal:  Cell Cycle       Date:  2002 Sep-Oct       Impact factor: 4.534

Review 2.  Validating survivin as a cancer therapeutic target.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

3.  Survivin inhibits apoptosis in cytotrophoblasts.

Authors:  A Shiozaki; K Kataoka; M Fujimura; H Yuki; M Sakai; S Saito
Journal:  Placenta       Date:  2003-01       Impact factor: 3.481

4.  Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis.

Authors:  M K Sharief; M A Noori; M R Douglas; Y K Semra
Journal:  Eur J Neurol       Date:  2002-09       Impact factor: 6.089

5.  Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.

Authors:  Teruo Endoh; Naoki Tsuji; Koichi Asanuma; Atsuhito Yagihashi; Naoki Watanabe
Journal:  Exp Cell Res       Date:  2005-05-01       Impact factor: 3.905

6.  Expression levels of the inhibitor of apoptosis survivin in testes of patients with normal spermatogenesis and spermatogenic failure.

Authors:  Steffen Weikert; Mark Schrader; Markus Müller; Wolfgang Schulze; Hans Krause; Kurt Miller
Journal:  Fertil Steril       Date:  2005-04       Impact factor: 7.329

7.  Survivin mRNA is down-regulated during early Xenopus laevis embryogenesis.

Authors:  Cary R Murphy; Jaime L Sabel; Anthony D Sandler; John M Dagle
Journal:  Dev Dyn       Date:  2002-12       Impact factor: 3.780

8.  Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines.

Authors:  Fengzhi Li; Xiang Ling; Huayi Huang; Lisa Brattain; Pasha Apontes; Jianguo Wu; Lise Binderup; Michael G Brattain
Journal:  Oncogene       Date:  2005-02-17       Impact factor: 9.867

9.  The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells.

Authors:  Seiji Fukuda; Richard G Foster; Scott B Porter; Louis M Pelus
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

10.  Overexpression of TIAP/m-survivin in thymocytes enhances cell proliferation.

Authors:  Satosi Hikita; Masahiko Hatano; Atsushi Inoue; Nobuyuki Sekita; Koichi Kobayashi; Masayuki Otaki; Takeshi Ogasawara; Seiji Okada; Hiroyuki Hirasawa; Takeshi Tokuhisa
Journal:  Mol Immunol       Date:  2002-10       Impact factor: 4.407

View more
  40 in total

1.  Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter.

Authors:  Qiuying Cheng; Xiang Ling; Andrew Haller; Takahito Nakahara; Kentaro Yamanaka; Aya Kita; Hiroshi Koutoku; Masahiro Takeuchi; Michael G Brattain; Fengzhi Li
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  Correlation between survivin genetic polymorphisms and lung cancer susceptibility.

Authors:  Guifang Guo; Qiang Zhang; Zhengang Yu; Junjuan Li; Zhaolei Ding; Juan Li; Wei Tan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 3.  Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Authors:  Fengzhi Li; Tao Jiang; Qingyong Li; Xiang Ling
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

4.  Integrated analysis of preclinical data to support the design of the first in man study of LY2181308, a second generation antisense oligonucleotide.

Authors:  Sophie Callies; Valérie André; Bharvin Patel; David Waters; Paul Francis; Michael Burgess; Michael Lahn
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

Review 5.  Survivin study: an update of "what is the next wave"?

Authors:  Fengzhi Li; Xiang Ling
Journal:  J Cell Physiol       Date:  2006-09       Impact factor: 6.384

6.  Antisense RNA of survivin gene inhibits the proliferation of leukemia cells and sensitizes leukemia cell line to taxol-induced apoptosis.

Authors:  Wenhan Li; Xiaojuan Wang; Ping Lei; Qing Ye; Huifen Zhu; Yue Zhang; Jinfang Shao; Jing Yang; Guanxin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

7.  Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells.

Authors:  Jin-bo Wang; Li-li Qi; Shui-di Zheng; Tian-xing Wu
Journal:  J Zhejiang Univ Sci B       Date:  2009-02       Impact factor: 3.066

8.  Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

Authors:  Jae Yeon Chun; Yan Hu; Elaine Pinder; Jianguo Wu; Fengzhi Li; Allen C Gao
Journal:  Mol Cancer Ther       Date:  2007-09       Impact factor: 6.261

9.  The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney.

Authors:  Philipp Lechler; Xiaoqing Wu; Wanja Bernhardt; Valentina Campean; Susanne Gastiger; Thomas Hackenbeck; Bernd Klanke; Alexander Weidemann; Christina Warnecke; Kerstin Amann; Dirk Engehausen; Carsten Willam; Kai-Uwe Eckardt; Franz Rödel; Michael Sean Wiesener
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

Review 10.  Pertinence of apoptosis markers for the improvement of in vitro fertilization (IVF).

Authors:  D Haouzi; S Hamamah
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.